Case Study: MacroGenics achieves streamlined clinical data validation with Certara’s Pinnacle 21 Enterprise

MacroGenics® Optimizes Validation and Issue Management with Pinnacle 21® Enterprise

MacroGenics, a Maryland-based biopharmaceutical company, faced challenges with manual and inconsistent processes for clinical data validation. Their team struggled with outsourced tasks and inefficient communication with vendors. To address this, they partnered with Certara to implement its Pinnacle 21 Enterprise platform.

Certara's solution provided a centralized platform that streamlined validation and issue management. This enabled standardized processes and improved collaboration, resulting in significant time savings for MacroGenics. The team gained the ability to continuously validate data throughout a study's lifecycle, leading to higher data quality and greater confidence in their submissions.

MacroGenics

Daner Li

Director, Clinical Programming